Price$22.77-0.15 (-0.63%)
01:45 PM07:45 PM
News · 26 weeks19-67%
2025-10-262026-04-19
Mix1390d
- SEC Filings5(38%)
- Earnings3(23%)
- Other3(23%)
- Insider2(15%)
Latest news
25 items- PRPediatrix Medical Group 2026 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 5, 2026Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 5, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2026. A detailed press release will be issued the morning of May 5, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. About Pediatrix Medical Group Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children acr
- SECSEC Form DEFA14A filed by Pediatrix Medical Group Inc.DEFA14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECSEC Form DEFA14A filed by Pediatrix Medical Group Inc.DEFA14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECSEC Form DEF 14A filed by Pediatrix Medical Group Inc.DEF 14A - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- PRPediatrix Expands Maternal Health Services in Tennessee in Partnership with Tennessee Maternal-Fetal MedicineMaternal-Fetal Medicine Specialists of Tennessee Provides Vital Care for Greater Nashville Area Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced its expansion in Middle Tennessee through a partnership with Tennessee Maternal-Fetal Medicine, further advancing its commitment to delivering high-quality maternal-fetal care. The practice will continue to serve patients at five locations throughout the Greater Nashville area as Maternal-Fetal Medicine Specialists of Tennessee under the Pediatrix Medical Group banner. "We are pleased to welcome Tennessee Maternal-Fetal Medicine to the Pediatrix family," said Mark Ordan, Chief Executive Officer
- PRPediatrix Welcomes Two Nationally Renowned Physician LeadersDr. James Barry, who will join as Chief Clinical Quality & Transformation Officer, and Dr. Jochen Profit, who will serve as Chief Quality Advisor, bring extraordinary reputations as care quality experts Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is pleased to announce that James Barry, M.D., MBA, will soon join the organization as Chief Clinical Quality & Transformation Officer. Jochen Profit, M.D., MPH, will join Dr. Barry as Chief Quality Advisor. "We are thrilled to welcome two nationally renowned physician leaders to Pediatrix and Obstetrix," said Mark Ordan, Chair of the Board and CEO. "Quality care is at the heart of everything that we do a
- INSIDEREVP, CFO and Treasurer Rossi Kasandra H covered exercise/tax liability with 3,676 shares, decreasing direct ownership by 5% to 73,300 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDEREVP, GC, Chief Admin Off & Sec Moore Mary Ann E was granted 39,925 shares and covered exercise/tax liability with 26,931 shares, increasing direct ownership by 10% to 149,236 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- PRPediatrix Medical Group Announces 47th Annual NEO: The Conference for NeonatologyLeading Educational Event Brings Together Neonatal-Perinatal Medicine Clinicians Dedicated to Improving Outcomes in Newborn Care Pediatrix® Medical Group, Inc. (NYSE:MD), a leading provider of physician services, is proud to host the 47th annual NEO: The Conference for Neonatology, taking place Feb. 25-27 in Las Vegas. NEO brings together top neonatology experts to discuss current issues and new advances in neonatal medicine. For over 45 years, Pediatrix has been a trusted leader in neonatology, caring for or providing diagnostics to approximately one-quarter of all newborn babies in the U.S. The national rate of preterm birth remains at an all-time high at 10.4%, meaning about 380,00
- SECSEC Form 10-K filed by Pediatrix Medical Group Inc.10-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECPediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- PRPediatrix Medical Group Reports Fourth Quarter ResultsPediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.40 per share for the three months ended December 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.50. For the 2025 fourth quarter, Pediatrix reported the following results: Net revenue of $494 million; Net income of $34 million; and Adjusted EBITDA of $66 million. "Our fourth quarter operating results were in line with our revised upward expectations and reflected solid same-unit revenue growth, partially offset by an increase in variable practice incentive compensation," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "Ou
- PRPediatrix Medical Group 2025 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 19, 2026Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Thursday, February 19, 2026 at 9:00 a.m. ET to discuss results from operations for the quarter ended December 31, 2025. A detailed press release will be issued the morning of February 19, 2026 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies
- INSIDERChief Executive Officer Ordan Mark S sold $515,430 worth of shares (23,000 units at $22.41), decreasing direct ownership by 7% to 302,805 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Rucker Michael A. sold $240,994 worth of shares (10,478 units at $23.00), decreasing direct ownership by 15% to 59,101 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERDirector Linynsky Laura A sold $216,500 worth of shares (10,000 units at $21.65), decreasing direct ownership by 24% to 32,232 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- SECSEC Form 10-Q filed by Pediatrix Medical Group Inc.10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- SECPediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- PRPediatrix Medical Group Reports Third Quarter ResultsRaises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67. For the 2025 third quarter, Pediatrix reported the following results: Net revenue of $493 million; Net income of $72 million; and Adjusted EBITDA of $87 million. "Our operating results for the third quarter exceeded our expectations and were driven by a combination of reimbursement-related factors, including strong collection activity, higher patient acuity and slightly favorable payor mix, a
- PRPediatrix Medical Group 2025 Third Quarter Conference Call/Webcast Scheduled for Monday, November 3, 2025Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Monday, November 3, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended September 30, 2025. A detailed press release will be issued the morning of November 3, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and
- INSIDERDirector Mceachin Thomas gifted 54,646 shares, decreasing direct ownership by 83% to 11,427 units (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- SECPediatrix Medical Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)
- PRPediatrix Medical Group Announces $250 Million Share Repurchase ProgramPediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today announced that its Board of Directors has authorized a share repurchase program of up to $250 million of the Company's outstanding common stock. "In view of our strong cash flow, current and forecasted cash balances and relatively low debt levels, our Board has authorized a $250 million share repurchase program, which we plan to use opportunistically," said Mark S. Ordan, Chair of the Board and Chief Executive Officer. "We will weigh the use of the repurchase program continually against other potential strategic uses of cash to provide the best long-term return to our shareholders and the strongest fu
- INSIDEREVP, Chief Invest & Strategy Neeb Don Gregory was granted 81,346 shares (SEC Form 4)4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)
- INSIDERSEC Form 3 filed by new insider Neeb Don Gregory3 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)